1GRF

Grifols S.A. is a global healthcare company that specializes in the development and production of plasma-derived medicines and biopharmaceuticals. Its products are used in transfusion medicine and are designed to support patients with chronic and rare diseases. Grifols operates in various segments, including biopharma and diagnostics, and serves customers worldwide, contributing to health and quality of life through its focus on plasma and life sciences.